Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2125 of 3284 entries
View as:

Chest Pain Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT00251901 Org: User:
Start: 05/31/04 End: 07/31/05 Due: 07/31/06

A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin.

Phase: N/A Priority: Normal
NCT ID: NCT05787002 Org: User:
Start: 03/09/23 End: 05/15/23 Due: 05/15/24

Survey Examining the Frequency and Severity of Acid Related Symptoms While Taking Nexium

Phase: N/A Priority: Normal
NCT ID: NCT01130935 Org: User:
Start: 05/31/10 End: 11/30/10 Due: 11/30/11

Open Label Arimidex in Gynecomastia

Phase: N/A Priority: Normal
NCT ID: NCT00241436 Org: User:
Start: 06/30/05 End: 11/30/06 Due: 11/30/07

A Study to Evaluate the Effectiveness and Tolerability of a Second Maintenance Treatment in Participants With Ovarian Cancer, Who Have Previously Received Polyadenosine 5'Diphosphoribose [Poly (ADP Ribose)] Polymerase Inhibitor (PARPi) Treatment.

Phase: N/A Priority: Normal
NCT ID: NCT04239014 Org: User:
Start: 08/07/20 End: 01/25/21 Due: 01/25/22

Efficacy Study in Allergic Rhinitis Patients After Intranasal Administration of AZD8848

Phase: N/A Priority: Normal
NCT ID: NCT01185080 Org: User:
Start: 09/30/10 End: 01/31/12 Due: 01/31/13

Phase II Umbrella Study of Novel Anti-cancer Agents in Patients With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03334617 Org: User:
Start: 12/18/17 End: 09/11/26 Due: 09/11/27

Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT01692262 Org: User:
Start: 11/30/12 End: 06/30/14 Due: 06/30/15

Non-Interventional Study of Zoladex in Endometriosis

Phase: N/A Priority: Normal
NCT ID: NCT00938496 Org: User:
Start: 07/31/09 End: 02/29/12 Due: 02/28/13

Association of the Risk for Thrombotic Thrombocytopenia Syndrome and Exposure To COVID-19 Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT05252442 Org: User:
Start: 03/01/22 End: 07/11/23 Due: 07/11/24

Prevention of Gastric Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT00629512 Org: User:
Start: 03/31/01 End: 12/31/02 Due: 12/31/03

A Study of NT-112 in HLA-C*08:02-Positive Adult Subjects With Unresectable, Advanced, and/ or Metastatic Solid Tumors Positive for the KRAS G12D Mutation

Phase: N/A Priority: Normal
NCT ID: NCT06218914 Org: User:
Start: 04/04/24 End: 08/29/42 Due: 08/29/43

Safety of Oral Resin for Treatment of Hyperkalemia in Chinese Patients With Renal Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT05462119 Org: User:
Start: 08/22/22 End: 12/29/23 Due: 12/29/24

Single Oral Dose of 60 mg [14C]AZD9668 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01147549 Org: User:
Start: 06/30/10 End: 07/31/10 Due: 07/31/11

Management of Dyslipidemia in Adult Type 2 Diabetes Patients in India

Phase: N/A Priority: Normal
NCT ID: NCT01292018 Org: User:
Start: 02/28/11 End: 02/29/12 Due: 02/28/13

A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients.

Phase: N/A Priority: Normal
NCT ID: NCT02533453 Org: User:
Start: 01/28/16 End: 12/07/16 Due: 12/07/17

AZD0486 as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Phase: N/A Priority: Normal
NCT ID: NCT06526793 Org: User:
Start: 11/27/24 End: 06/14/29 Due: 06/14/30

A Study to Investigate the Blood Concentrations of 4 Different Oral Doses of Zibotentan in Healthy Non-Asian and Japanese Participants

Phase: N/A Priority: Normal
NCT ID: NCT06715670 Org: User:
Start: 12/05/24 End: 02/19/25 Due: 02/19/26

Polish Survey on the Efficacy of the Hypercholesterolemia Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01243255 Org: User:
Start: 12/31/10 End: 06/30/11 Due: 06/30/12

Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin

Phase: N/A Priority: Normal
NCT ID: NCT00819234 Org: User:
Start: 11/30/08 End: 11/30/09 Due: 11/30/10

Investigation of Specific Protein/Markers in Patients With Osteoarthritis of the Knee Having a Total Knee Replacement

Phase: N/A Priority: Normal
NCT ID: NCT01611441 Org: User:
Start: 12/31/11 End: 06/30/12 Due: 06/30/13

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

Phase: N/A Priority: Normal
NCT ID: NCT00528372 Org: User:
Start: 09/30/07 End: 07/31/10 Due: 07/31/11

Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05438303 Org: User:
Start: 06/13/22 End: 12/13/22 Due: 12/13/23

Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States

Phase: N/A Priority: Normal
NCT ID: NCT05329194 Org: User:
Start: 04/29/22 End: 10/02/25 Due: 10/02/26

A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06084884 Org: User:
Start: 12/14/23 End: 12/13/27 Due: 12/13/28